The Latest Breaking News from FDA

As psychedelic treatments gain traction, analysts predict triple-digit upside for this small-cap biotech stock.

Decision that overturned convention of deference to federal agencies could upend regulations on tobacco, drugs and medical bills

For the first time, cannabis plant would drastically shift federal legal status from narcotic to regulated medication

Learn about the FDA's ban on BVO in food products and the health risks associated with this additive. Stay informed and make healthier choices for your diet.

Sofwave, a non-invasive high-frequency device, toned my arms when weight lifting couldn't.

An average adult is able to consume four to five cups of coffee per day

A renaissance is stirring in cholesterol treatment, and it could drive Merck, Novartis and other stocks higher, while delivering new choices for millions of patients.

Union for civil servants claimed Home Office staff could be open to prosecution if Strasbourg rulings on Rwanda ignored

The healthcare industry is set to grow significantly due to technological advances, an aging population, and increasing demand for quality healthcare. To that end, it could be wise to buy fundamentally strong healthcare stocks like Abbott Laboratories (ABT), Stryker (SYK), and Centene (CNC), which are set to benefit from these…

FDA revoked the authorization for the use of brominated vegetable oil, a common food additive used in sports drinks and sodas, citing safety concerns.

The FDA will no longer allow BVO in food due to safety concerns revealed in studies.